Enhancement of protein kinase C-mediated EGF receptor phosphorylation by auranofin.
暂无分享,去创建一个
[1] M. Froscio,et al. Auranofin enhances phosphorylation of putative substrates of protein kinase C in human platelets. , 1988, Biochemical pharmacology.
[2] S. Crooke,et al. Effect of auranofin and other gold complexes on the activity of phospholipase C. , 1987, Molecular pharmacology.
[3] N. Hurst,et al. Auranofin increases the affinity of phorbol dibutyrate receptors in chronic lymphocytic leukemia cells (B cells). , 1987, Journal of immunology.
[4] M. Froscio,et al. Inhibition of epidermal growth factor binding to HeLa cells by auranofin. , 1987, Biochemical pharmacology.
[5] S. Crooke,et al. The cellular and molecular pharmacology of auranofin and related gold complexes. , 1986, Scandinavian journal of rheumatology. Supplement.
[6] A. Ullrich,et al. The complete primary structure of protein kinase C--the major phorbol ester receptor. , 1986, Science.
[7] G. Nuki,et al. Studies of the effect of D-penicillamine and sodium aurothiomalate therapy on superoxide anion production by monocytes from patients with rheumatoid arthritis: evidence for in vivo stimulation of monocytes. , 1986, Annals of the rheumatic diseases.
[8] J. Downward,et al. Autophosphorylation and protein kinase C phosphorylation of the epidermal growth factor receptor. Effect on tyrosine kinase activity and ligand binding affinity. , 1985, The Journal of biological chemistry.
[9] R. Davis,et al. Tumor-promoting phorbol diesters cause the phosphorylation of epidermal growth factor receptors in normal human fibroblasts at threonine-654. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[10] R. Davis,et al. sn-1,2-Dioctanoylglycerol. A cell-permeable diacylglycerol that mimics phorbol diester action on the epidermal growth factor receptor and mitogenesis. , 1985, The Journal of biological chemistry.
[11] R. N. Brogden,et al. Auranofin. A preliminary review of its pharmacological properties and therapeutic use in rheumatoid arthritis. , 1984, Drugs.
[12] B. Seligmann,et al. Auranofin affects early events in human polymorphonuclear neutrophil activation by receptor-mediated stimuli. , 1984, Journal of immunology.
[13] M. Waterfield,et al. Anti epidermal growth factor receptor monoclonal antibodies , 1983 .
[14] P. Davis,et al. A longitudinal study of in vitro tests for lymphocyte function in rheumatoid arthritis , 1978, Annals of the rheumatic diseases.
[15] H. Herschman,et al. Variants of 3T3 cells lacking mitogenic response to epidermal growth factor. , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[16] G. Todaro,et al. Nerve growth factor receptors on human melanoma cells in culture. , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[17] S. Cohen,et al. Epidermal growth factor and a new derivative. Rapid isolation procedures and biological and chemical characterization. , 1972, The Journal of biological chemistry.
[18] U. K. Laemmli,et al. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.